It is well known that the glucocorticoid receptor (GR) plays a crucial role in mediating the negative feedback regulation of the HPA axis92,93 and, recently, several studies have investigated the GR expression levels and functionality in patients with MDD. This evidence concerns the gene NR3C1 and major depressive disorder.